Traduction de «colour professional type s negative » (Anglais → Français) :

23. Takes the view that follow-up and analysis are important on a number of fronts with clear budgetary links, such as the restructuring of directorates-general, efficient human resources management and a professional staff policy, a cost- and energy-efficient buildings policy in terms of location, non-discrimination, EMAS, public procurement and action taken in response to budget discharge recommendations; emphasises the need for continuous follow-up and analysis of Parliament's budget implementation in general; recalls, in this con ...[+++]text, the negative media coverage resulting from subsidies being given to relatives of Parliament staff members, and calls for the Secretariat to scrutinise in advance any subsidising of event-type activities and bring it to the attention of the committee responsible;

23. Takes the view that follow-up and analysis are important on a number of fronts with clear budgetary links, such as the restructuring of directorates-general, efficient human resources management and a professional staff policy, a cost- and energy-efficient buildings policy in terms of location, non-discrimination, EMAS, public procurement and action taken in response to budget discharge recommendations; emphasises the need for continuous follow-up and analysis of Parliament’s budget implementation in general; recalls, in this con ...[+++]text, the negative media coverage resulting from subsidies being given to relatives of Parliament staff members, and calls for the Secretariat to scrutinise in advance any subsidising of event-type activities and bring it to the attention of the committee responsible;

Question No. 138 Hon. John McKay: With respect to Canadians with diabetes who suffer severe and life-threatening adverse reactions to synthetic insulin and are unable to obtain domestically, an alternative animal-based insulin: (a) what actions has Health Canada taken or will take to ensure that Canadians who require such medication will continue to have access to it; (b) is the government (i) investigating methods of producing the medication via public funds or public-private partnership, (ii) initiating a process seeking approval of the drug for domestic production and distribution, (iii) initiating a consultation process with the manufacturers of animal insulin seeking domestic production and distribution, (iv) providing incentives to m ...[+++]anufacturers to produce animal insulin domestically, (v) securing a guarantee from the manufacturer that the drug will be permanently available, (vi) stockpiling the medication to ensure near-term supply; (c) what has Health Canada done or what will it do to ensure that these Canadians receive financial assistance due to high costs as a result of provincial health insurance plans not covering certain medications or treatments; (d) what action has Health Canada taken or will take to ensure (i) that people who suffer negative effects from synthetic insulin are aware of and have access to proper treatment as well as expanded choice in treatment options, (ii) that medical professionals who are responsible for treating Canadians with diabetes are aware of the availability of alternative forms of medication such as beef and pork based insulin; (e) what action has Health Canada taken or will take to ascertain how many Canadians suffer adverse reactions from synthetic insulin; (f) has Health Canada investigated or will be investigating the implementation of a protocol to address this issue, if not, why have steps not been taken to address this issue; and (g) does the lack of the availability of this type of medically necessary treatme ...

There is a real concern about those types of bills coming forward, but in Bill C-17 we should really focus on the judicial compensation and getting through this in an orderly and professional manner in the House without negative political interference.